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ABSTRACT
Introduction: Promotion of healthy pregnancies has
gained high priority in the Netherlands because of the
relative unfavourable perinatal outcomes. In response, a
nationwide study Healthy Pregnancy 4 All (HP4ALL) has
been initiated. One of the substudies within HP4ALL
focuses on preconception care (PCC). PCC is an
opportunity to detect and eliminate risk factors before
conception to optimise health before organogenesis and
placentation. The main objectives of the PCC substudy
are (1) to assess the effectiveness of a recruitment
strategy for the PCC health services and (2) to assess
the effectiveness of individual PCC consultations.
Methods/analysis: Prospective cohort study in
neighbourhoods of 14 municipalities with perinatal
mortality and morbidity rates exceeding the nation’s
average. The theoretical framework of the PCC substudy
is based on Andersen’s model of healthcare utilisation
(a model that evaluates the utilisation of healthcare
services from a sociological perspective). Women aged
18 up to and including 41 years are targeted for
utilisation of the PCC health service by a four armed
recruitment strategy. The PCC health service consists
of an individual PCC consultation consisting of
(1) initial risk assessment and risk management
and (2) a follow-up consultation to assess adherence to
the management plan. The primary outcomes regarding
the effectiveness of consultations is behavioural change
regarding folic acid supplementation, smoking
cessation, cessation of alcohol consumption and
illicit substance use. The primary outcome regarding
the effectiveness of the recruitment strategy is the
number of women successfully recruited and the
outreach in terms of which population is reached in
comparison to the approached population. Data
collection consists of registration in the database of
women that enrol for a visit to the individual PCC
consultations (women successfully recruited), and
preconsultation and postconsultation measurements
among the included study population (by
questionnaires, anthropometric measurements and
biomarkers). Sample size calculation resulted in a
sample size of n=839 women.
Ethics and dissemination: Approval for this study
has been obtained from the Medical Ethical Committee
of the Erasmus Medical Center of Rotterdam (MEC
2012-425). Results will be published and presented at
international conferences.
BACKGROUND
The Healthy Pregnancy 4 All (HP4ALL)
study was initiated because of the relatively
high perinatal mortality rate of 10 per 1000
births, ranking the Netherlands at an
unfavourable position in Europe.1 A huge
concern was the inequality in the perinatal
mortality rate within the country: deprived
neighbourhoods were found to have an up
Strengths and limitations of this study
▪ This study is rolled out in a ‘real time setting’ in
collaboration with municipalities, public health
services and curative care. Strategy is described
thoroughly and evaluation aims to assess factors
that influence implementation so that the pro-
gramme’s method can be adopted and adapted
to fit other local settings.
▪ It is acknowledged to be a true challenge to
reach prospective parents in the preconception
period. In this study, a predefined strategy with
active and passive recruitment components is
employed to promote uptake of preconception
care (PCC) consultations. Its effectiveness is
seen as one of the primary study outcomes.
▪ For the assessment of the effectiveness of PCC
consultations—this study relies on biomarkers
rather than on self-reported outcomes only in
the assessment of the effectiveness of PCC con-
sultations. To date, this has only been carried
out in a PCC study regarding single outcomes
(folic acid or smoking).
van Voorst SF, et al. BMJ Open 2015;5:e006284. doi:10.1136/bmjopen-2014-006284 1
Open Access Protocol
to four times higher perinatal mortality rate than
average.2 Societal, professional and political debates
about how to improve perinatal health in the
Netherlands dominated the policy agenda. One of the
results was the launch of the HP4ALL study—commis-
sioned by the Dutch Ministry of Health and Welfare—in
May 2011.3 4
The objective of the HP4ALL study is to develop
evidence-based strategies to improve perinatal health by
interventions in the preconception or the antenatal
period, which reduce adverse pregnancy outcomes.
Accordingly, HP4ALL is divided into two substudies: the
Preconception Care study (PCC)—a prospective cohort
study—and the antenatal Rotterdam Risk Assessment
(R4U) study—a cluster randomised controlled trial. This
paper concentrates on the PCC substudy.
The rationale of PCC and its delivery approaches
The rationale of PCC originates in the growing recogni-
tion that the embryonic development and placentation
phase is critical for the outcome of the pregnancy.5 PCC
is a set of interventions that aims to identify and modify
biomedical, behavioural and social risks to a woman’s
health or pregnancy outcome through prevention and
management.6
The preconception period can be seen as the earliest
link between maternal and newborn health. Therefore,
it has been recognised as a pivot point which can be uti-
lised to improve perinatal health.7–9 In the Netherlands,
85% of the perinatal mortality cases were preceded by
small for gestational age (SGA), premature birth and
congenital anomalies10 11 In theory, many risk factors
for these problems are present and potentially detect-
able and treatable/manageable before conception.5 7 By
the time a women enters antenatal care, a large part of
organogenesis has taken place. PCC should therefore be
regarded as a necessary additional component to the
obstetric care system in the improvement of perinatal
outcomes.
Organisation of PCC
PCC can be organised in three forms: (1) collective PCC
consisting of interventions targeted at the general public
(eg, with group education or national campaigns);
(2) general individual PCC consisting of individual con-
sultations among couples contemplating pregnancy
among the general public; (3) specialist individual PCC
consisting of individual consultations among couples
contemplating pregnancy with complex risk factors.12
These forms can be integrated in different approaches
for delivery, dependent on the health system (eg, primary
care, hospital based, PCC clinic) and the targeted audi-
ence (eg, high-risk population or general public).13
Individual PCC is a unique opportunity for profession-
ally led PCC, which addresses general risk factors and
personal risk factors after systematic screening.
Furthermore, individual PCC is an opportunity to
deliver PCC in a responsive fashion—so that besides the
systematic standard risk factor screening the individual
patient’s needs or preferences can be met.14 Thus,
Individual PCC consultations are seen as the form of
PCC to implement in the PCC substudy.
Recruitment for PCC
The concept of visiting a healthcare professional for
PCC is not common in the Netherlands as well as in
many other countries. First, the uptake of PCC requires
that a pregnancy is planned. An explanation for the low
uptake of PCC can be sought in the unfamiliarity of
women or couples with the availability and potential
beneﬁts of the health service.15–17 Women or couples
could assume that they are healthy and that it is not
necessary to discuss their pregnancy wish with a profes-
sional. Women who are aware of risks might believe that
nothing can be done to inﬂuence the course of a preg-
nancy in the future. Besides beliefs, actual barriers to
attend PCC could also play a role. For instance, a
woman’s or couples’ willingness to disclose their preg-
nancy wish to a professional is a known barrier.17 Simply
delivering PCC to women or couples on request does
not seem to be sufﬁcient to provide PCC at a scale to
improve perinatal health. An active recruitment
approach is necessary. Different active recruitment
approaches are described in the literature. Wallace
et al18 describe that the opportunistic approach of
women during daily care is utilised most often by
primary caregivers. However, despite the fact that
couples in the general public are known to have at least
more than one risk factor,19 many women/couples of
reproductive age do not request a PCC consultation
from their general practitioner (GP). An opportunistic
approach is not feasible for midwives as they rarely see
non-pregnant women. One trial employs the approach
of inviting women through invitational letters.20 These
approaches, however, require efforts from caregivers in
an already stressed system; and the effectiveness is
unknown. An evidence-based strategy is necessary to
create an outreach for individual PCC consultations in
order to improve perinatal health on a larger scale.
The main objective of this study is to implement and
evaluate a local recruitment strategy for individual PCC
and to promote and evaluate (health) behaviour change
by delivery of PCC consultations in primary care. This
paper provides an overview of the design and method-
ology of the HP4ALL PCC study.
METHODS/DESIGN
Key attributes of the study
The PCC study is designed as a community-based study
with a high-risk approach in a primary care setting with
tools to improve the uniformity of the health message.
This section describes the key concepts of the study:
▸ The high-risk approach: The Ministry of Health commis-
sioned the HP4ALL study to target high-risk popula-
tions. After ranking the municipalities with the
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highest perinatal mortality and morbidity in the
country, 14 municipalities were selected as candidates
for participation (selection described elsewhere).4
The key approach of HP4ALL is to roll out the inter-
ventions in high-risk neighbourhoods—meaning
neighbourhoods with rates of adverse perinatal out-
comes above the average of the selected municipal-
ities. It is presumed that women in these
neighbourhoods can beneﬁt the most from interven-
tions in the HP4ALL study. Prevalence of risky life-
style behaviours in the preconception phase is not
exactly known as there is no surveillance among
women contemplating pregnancy and risky beha-
viours tend to be under-reported during pregnancy.
With regard to folic acid supplementation, a recent
Dutch study conducted among a multiethnic popula-
tion reported that 40% of pregnant women had used
folic acid supplements before conception.21 A differ-
ent study reported that of 7106 pregnant women, 8%
smoked in the ﬁrst trimester only and 17% continued
smoking throughout pregnancy.22 In total, 35—50%
of women are estimated to continue their alcohol
consumption during pregnancy.23 The HP4ALL study
will provide more information regarding risk beha-
viours before and in pregnancy in these high-risk
neighbourhoods.
▸ The community-based approach: A community-based
approach has advantages as it (1) reaches popula-
tions which are hard to reach by ensuring trust: col-
laboration with local health authorities in a
community-based approach provides the opportunity
that the target population is approached by profes-
sionals they know and mostly trust; (2) promotes col-
laboration and local support as it draws together the
sectors necessary for optimal outreach.24
▸ A primary care approach: GPs and midwives practising
in the high-risk neighbourhoods are recruited to
deliver individual PCC consultations. They were
selected because they can deliver the intervention in
a responsive fashion, because they are familiar with
the target population and by arranging them to
provide the PCC consultations, accessibility of PCC is
ensured.
▸ Tools for the consistency of health messages: PCC for
the general population necessitates a thorough
risk factor screening. Therefore, GPs and midwives
are facilitated with tools and training to ensure
consistency, which is important as different health
messages reduce the effectiveness of interventions.14
Theoretical framework of the HP4ALL PCC substudy
The delivery of PCC in the PCC substudy is based on
Andersen’s model of healthcare Utilisation.25
Andersen deﬁnes the utilisation of a health service
and other personal health behaviours as an outcome.
These outcomes are a function of the predisposition
(to utilise the healthcare service) and enabling or
impeding factors (to utilise the healthcare service)
and perceived and objective need (to utilise the
healthcare service). This model has been used to
understand utilisation of PCC services and other
healthcare services (oral health services, mental health
services, primary care).26 27 Figure 1 should be read
from left to right: The PCC substudy intervenes in the
environment in order to target the population to achieve
the outcomes on the right.
▸ The environment: The study entails two organisational
changes in the environment: First, individual PCC
consultations are made available. Second, a strategy
to recruit eligible women to utilise the PCC services is
employed (see ﬁgure 2).
▸ The population: The study aims to target women of
reproductive age (deﬁned as 18 up to and including
41 years) living in municipalities with high perinatal
mortality and morbidity rates with a speciﬁed recruit-
ment strategy. Women will, however, decide individu-
ally, within their own context, whether they will use
the healthcare service and/or change their health
behaviours. We hypothesize this decision to be a func-
tion of:
– Predisposing factors: In accordance with Andersen’s
model of healthcare utilisation, we contemplate
that a woman’s decision to utilise PCC will depend
on a function of her health beliefs and attitude
towards the preconception health service and a
healthy pregnancy, social inﬂuences and demo-
graphic factors.
– Enabling factors: The targeted woman can be stimu-
lated to visit (or be impeded from visiting) the PCC
health service by community factors (eg, a good
infrastructure to attend a PCC consultation) or by
individual factors (eg, speaking a different language
than the PCC care provider can be a barrier to
attending the PCC consultations).
– Need: The targeted woman needs to feel a need to
utilise the service. There are two kinds of need: (1)
an objective need (the service is necessary in terms
of medical risks) and (2) a perceived need (the
service is perceived as necessary by the woman
herself). Perceived need can be related to the
objective need, but this is not necessarily the case.
Factors from the literature or those which we
hypothesised to inﬂuence the objective and/or per-
ceived need for a PCC consultation are mentioned
in ﬁgure 1. Need, as a resultant of a perceived need
and objective need, is thought to be inﬂuenced by
predisposing characteristics (eg, knowledge regard-
ing risks, social network to point out the relevance
of PCC for the individual).
▸ The outcomes: The primary outcomes of the PCC sub-
study are reduction of preconception risks by the (1)
utilisation of PCC health services and (2) behavioural
change regarding preconception risk behaviours.
Reduction of preconception risk factors is thought to
subsequently reduce (the risk for) perinatal morbid-
ity and mortality.
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The intervention
As displayed in ﬁgure 3, the PCC consultation consists of
two visits to a participating GP or midwife in the course
of 3 months. During the ﬁrst consultation, systematic
risk assessment is performed and a tailored manage-
ment plan provided to address risk factors. Caregivers
evaluate whether goals are reached or whether add-
itional measures are necessary. Consultations are sup-
ported and archived with PCC tools (see box 1).28 29
The tool for risk assessment (Zwangerwijzer in Dutch) is
a validated tool.30 When women participate in the
cohort study as study participants, extra data are col-
lected to assess the effectiveness of the care provided
(see section on data collection).
Study population
All women aged 18 up to and including 41 years (the adult
reproductive lifespan) who make an appointment at the
PCC health service are enrolled (registered in the
database) to assess the effectiveness of the recruitment
strategy. The additional criteria for inclusion in the cohort
study to assess the effectiveness of PCC are: (1) a pregnancy
wish (regardless of in which phase) and (2) voluntary par-
ticipation. Exclusion criteria are: (1) no permission to be
encountered about participation in the study (2) non-
response to approach for inclusion (3) not speaking one of
the following languages (Dutch, English, Turkish, Polish or
Arabic) (4) cancellation/no-show at the appointment.
Recruitment and enrolment
The recruitment strategy consists of four components
(see ﬁgure 2):
1. An invitational letter from the municipal public
health service;
2. An invitational letter from participating general prac-
tices to their own patients;
3. Youth Health Care Physicians or nurses inform
parents who visit the routine check-ups at the youth
healthcare centre for their child with an information
leaﬂet containing the names of the participating
practices;
4. Referral by a preconception health educator after
PCC education sessions. (A preconception health
educator is a person from the peer group (the local
community) who has completed certiﬁed training in
health communication skills/preconception health).
All female applicants for the PCC healthcare services
are registered. These women are sent an information
letter followed by a telephone call for individual
counselling about participation in the study by the
research team. Participants who agreed to take part
in the study signed an informed consent form.
Women receive the same PCC regardless of participa-
tion in the study; participation requires the partici-
pant to partake in data collection (questionnaires
and laboratory tests) parallel to the care she receives.
Figure 1 The Framework for the Healthy Pregnancy 4 All—Preconception Care substudy.
Figure 2 The recruitment strategy of the Healthy Pregnancy
4 All—Preconception Care substudy.
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Outcomes
The primary outcome regarding the effectiveness of the
individual PCC consultations is behavioural change.
Behavioural change is assessed for folic acid supplementa-
tion, smoking, alcohol consumption and illicit substance
use. These four preconception health behaviours
were chosen as primary outcomes due to their prevalence
and their impact on the fetus and modiﬁability.31–36
Differences in these behaviours are assessed by premea-
surement and postmeasurement by questionnaires
(self-reported changes) and biomarkers (biochemical
assessment of behavioural change). Biomarkers are used,
as it is known that self-reported outcomes can show socially
desirable answers. For example, in case of the use of folic
acid supplements, a Dutch study found an over-report of
22% for self-reported folic acid supplement use.21
The primary outcome regarding the effectiveness of
the recruitment strategy is the utilisation of the PCC ser-
vices of the programme. This is measured quantitatively
by the number of women who utilised the PCC pro-
gramme (women successfully recruited) in relation to
the number of women approached by the recruitment
strategy. Second, the effectiveness of the recruitment
strategy is assessed in terms of the outreach: by assessing
characteristics of women reached. This includes basic
demographics of women who were successfully recruited
and identiﬁcation of predisposing factors, need and
enabling factors according to Andersen’s model of
healthcare utilisation among women included in the
study. Data regarding the target group (all women aged
18 up to and including 41 years in the geographically
targeted area) are obtained from municipal administra-
tive records.
Outcomes, measures and data sources are presented
in table 1.
Data collection and measurement
The process of data collection is illustrated in ﬁgure 3.
All women who make an appointment are registered
in the Gemstracker (Generic Medical Survey Tracking
system) database.37 The Gemstracker system ﬁrst helps
keep a log of all the consultations. Furthermore, the
system assists in keeping a log of the inclusion process
after which it organises data collection within a speciﬁc
time track, by activating ﬁelds or questionnaires for
respondents or PCC providers.
Data collection consists of a questionnaire (question-
naires 1 and 2, respectively), anthropometric measure-
ments and laboratory tests, performed as a baseline
measurement (before the ﬁrst consultation) and
follow-up measurement (around the second
consultation).
Figure 3 Flow chart for enrolment and intervention and data collection.
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▸ Questionnaires: Questionnaire 1 is ﬁlled in prior to the
ﬁrst PCC visit. This questionnaire assesses the
characteristics of the study participant and health
behaviours regarding the primary outcomes and other
preconception risk factors. Questionnaire 2 is ﬁlled in
after 3 months to assess changes in health behaviour
regarding preconception risk factors. The question-
naires are ﬁlled in on paper or via the internet.
Participants were reminded up to two times to ﬁll in
the questionnaire. The questionnaires were available
in Dutch, English, Arabic, Turkish and Polish.
▸ Anthropometric measurements: PCC providers measure
the following anthropometric measurements at both
PCC visits: blood pressure (mm Hg), length (cm),
weight (kg), hip and waist circumference (cm).
These measurements were performed according to a
predeﬁned protocol.
▸ Laboratory tests: Data from the questionnaires regard-
ing the primary outcomes of behavioural change are
veriﬁed with biomarkers. Folic acid supplementation
is assessed by measuring red cell folate in the
serum.31 Smoking cessation is assessed by serum coti-
nine levels.38 39 Applying biomarkers for alcohol con-
sumption is challenging because diagnostic accuracy
is generally moderate and diagnostic properties differ
over different alcohol consumption quantities and
patterns. Ideally, one would match a biomarker to the
presumed alcohol consumption (quantitatively in
time) of the study population. However, the preva-
lence of alcohol consumption is difﬁcult to predict as
there is a lack of consensus regarding the classiﬁca-
tion of alcohol consumption.40 Numbers in the
general population and in cohorts of pregnant
women vary.35 As there is no consensus regarding
safety of alcohol consumption in the preconception
phase, the recommendation is to not consume
alcohol in the preconception phase. Thus, we will be
interested in biomarkers for any level of alcohol con-
sumption. To detect alcohol drinking in the heavy
end of the spectrum, we chose to use carbohydrate
deﬁcient transferrin (CDT%).41 As a biomarker to
assess the mild–moderate drinking spectrum, we will
explore the availability of ethylgluconeride (EtG) or a
serum test of phosphatidylethanol (PEth) for the
mild–moderate drinking spectrum.42 Illicit substance
use will be tested with conventional urinary drug tests
(assessing amphetamines, barbiturates, benzodiaze-
pines, cannabinoids, cocaine, methadone, opioids
Box 1 Tools for delivery of preconception care in the Healthy Pregnancy 4 All—Preconception Care substudy
Box 1 Tools for delivery of PCC in the Healthy Pregnancy 4 All—PCC substudy
Standardised risk assessment instruments improve delivery of PCC, unify risk assessment and facilitate documentation needs. The Healthy
Pregnancy 4 All programme uses two tools:
The ZwangerWijzer Tool:
ZwangerWijzer is a self-administered questionnaire for couples designed to be filled in prior to consultation.
The questionnaire is freely accessible on the internet29 or on paper. The web-based survey has additional features: (1) additional information
is provided when a risk factor is present (2) a list of risk factors is generated, listing what should be discussed during the PCC consultation.
This list can be emailed to the PCC caregiver.
The questionnaire is adopted from The Preconception Health Assessment Form and a Family History Survey. It covers the following risk
domains and risk factors:
Background Lifestyle Medical
history
Obstetric and
gynaecological history
Family Work
Maternal
age
BMI
Ethnicity
Exposure to radiation
Smoking
Alcohol
Drugs
Eating disorders
Nutrition
Folic acid supplement
use
Vitamin A
Toxoplasmosis
Listeria
STDs
HIV
Rubella vaccination
(Chronic) illness
Prescribed
medication
Over-the-counter
drugs
Prior pregnancies
Pregnancy complications
Uterine anomalies
Prior gynaecological
surgeries
Family
history
consanguinity
Chemical exposure
Other exposure
Infectious agents
Shifts/irregular hours
Physically demanding
work
Stress
Zwangerwijzer is a validated tool.30
The Preconceptiewijzer Tool:
Preconceptiewijzer is a web-based PCC archive system complementary to the ZwangerWijzer questionnaire.28 Providers can create a PCC file
for their patients in which the questionnaire can be archived and the consultation(s) can be documented. The tool provides an overview
sheet in which present risk factors (identified in ZwangerWijzer) are linked to digital patient information leaflets and protocols for the care-
giver about these risk factors. The latter is a measure to improve the uniformity of health messages and interventions. Preconceptiewijzer is
available online; providers have an own account which is secured for own use. This account and technical support is freely available.
BMI, body mass index; PCC, preconception care; STD, sexually transmitted diseases.
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Table 1 Outcome assessment listed per study aim
Research aim Outcome measure Data source
Effectiveness of individual PCC consultations
Primary outcomes
Folic acid suppletion Self-reported folic acid use
Biomarker (erythrocyte folate) confirmed folic
acid suppletion
Questionnaire and blood analysis at first
consultation and 3 months after first
consultation
Smoking Self-reported smoking cessation
Biomarker (serum cotinine) confirmed smoking
cessation
Questionnaire and blood analysis at first
consultation and 3 months after first
consultation
Alcohol Self-reported cessation of alcohol consumption
Self-reported reduction of alcohol consumption
Biomarker (serum %CDT; urinary EtG or
PeTH) confirmed reduction or cessation of
alcohol consumption
Questionnaire and blood/urine analysis at first
consultation and 3 months after first
consultation
Illicit substance use Self-reported cessation of illicit substance use
Biomarker (drug assessment in urine)
confirmed cessation of illicit substance use
Questionnaire and urine analysis at first
consultation and 3 months after first
consultation
Effectiveness of recruitment strategy
Primary outcomes
Characteristics of the
cohort measured by
Andersen’s model
Characteristics of women who utilised the PCC
health service according to the framework of
the substudy (figure 1)
Questionnaire at first consultation
Outreach of the municipal
letter
Proportion of women successfully recruited
through the letter from the municipality in
relation to the number of women approached
with a letter from the municipal health service/
municipality
Characteristics of women successfully
recruited after receiving the letter from the
municipality in relation to characteristics of
women residing in the selected
neighbourhood(s)
Data on women successfully recruited (the
Gemstracker database) and data from women
included in the study (questionnaire 1).
(Anonymous) Municipal administrative records
provide characteristics of the target population:
all women aged 18–42 residing in the high-risk
neighbourhood
Outreach of the GP letter Proportion of women successfully recruited in
relation to the number of women approached
by a letter from their general practice.
Characteristics of these women in relation to
characteristics of women residing in the
selected neighbourhood(s)
Data on women successfully recruited (the
Gemstracker database) and data from women
included in the study (questionnaire 1).
(Anonymous) register of women who were sent
a letter by general practices.
(Anonymous) Municipal administrative records
provide characteristics of the target population:
all women aged 18–42 residing in the high-risk
neighbourhood
Outreach of the
Preconception health
educators
Proportion of women successfully recruited
after being approached about the service
during a peer health education session.
Characteristics of these women in relation to
characteristics of women residing in the
selected neighbourhood(s)
Data on women successfully recruited (the
Gemstracker database) and data from women
included in the study (questionnaire 1).
Questionnaires of participants of preconception
health education sessions
(Anonymous) Municipal administrative records
provide characteristics of the target population:
all women aged 18–42 residing in the high-risk
neighbourhood
Outreach of the Child
Welfare service
Proportion of women successfully recruited
after being approached during a visit to the
Child Welfare service
Characteristics of these women in relation to
characteristics of women residing in the
selected neighbourhood(s)
Data on women successfully recruited
(Gemstracker database) and data from women
included in the study (questionnaire 1).
(Anonymous) Municipal administrative records
provide characteristics of the target population:
all women aged 18–42 residing in the high-risk
neighbourhood
CDT, carbohydrate deficient transferrin; EtG, ethylgluconeride; PCC, preconception care; PeTH, phosphatidylethanol.
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(codeine, morphine, heroin, oxycodone, etc), phen-
cyclidine, propoxyphene, synthetic cannabinoids).
Providers are blinded to data from questionnaires
and from the mentioned biomarkers.
‘In case of no-show at either consultation, PCC provi-
ders are encouraged to provide a new appointment for
the consultation. If the woman does not attend the ﬁrst
PCC consultation, she will be included for the analysis of
the recruitment strategy. However, she will be excluded
from the PCC cohort. If a woman does not attend the
second PCC consultation, she will be asked to complete
her second questionnaire and where it is logistically
opportune, she will be asked to undergo a second labora-
tory assessment. She will be included in the outcome
assessment of the effectiveness trial in that case.
Data analysis and sample size calculation
Data analysis
Characteristics of the study population and preconcep-
tion health behaviours at baseline will be described con-
tinuously (mean or median, SD or IQR) or descriptively
(percentages and CIs).
Changes in preconception health behaviours will be
analysed paired. Preconsultation and postconsultation
differences will be expressed with mean differences and
SDs in continuous variables (in case of normality) or with
median and IQR (in case of skewed data). Student t tests
(in case of normality) or Wilcoxon Matched Pairs Test
(in case of skewed data) will be performed for hypothesis
testing. Dichotomous variables will be tested with the
exact binomial test. Signiﬁcance testing will be per-
formed two-sided with an α of 0.05. Regarding change in
folic acid supplementation and smoking cessation, one-
sided testing will be performed with an α of 0.025 (in line
with the hypothesis used for sample size calculation).
Regarding the effectiveness of the recruitment strat-
egy, utilisation of the PCC health service will be
expressed in percentages in relation to the number of
women approached by the recruitment strategy.
Characteristics of women who visit the PCC health
service will be assessed according to the framework for
utilisation of the PCC service (see ﬁgure 1).
Sample size calculation
Sample size calculation was performed for the two most
important primary outcomes: folic acid supplementation
and smoking cessation.
Regarding folic acid supplementation, 839 women are
needed in order to reject the null hypothesis (H0) that
the PCC service will lead to a 20% increase of folic acid
users in women who were not already using folic acid sup-
plements at baseline (assumptions for this power calcula-
tion were (1) the smallest clinically relevant difference
(‘Δ’) is a 20% increase of folic acid in non-users at base-
line, (2) the proportion of women using folic acid at base-
line is 30% (π0=30%),41 (3) a select dropout rate of 10%,
(4) pairwise analysis of results, (5) a statistical signiﬁcance
level of α<0.025 (one-sided correction for multiple testing
due to primary outcome measures) and (6) a power (1-β)
of 0.80). Regarding smoking cessation, 687 women are
needed to reject the null hypothesis (Ho) that the PCC
service will lead to a <5% decrease in smoking cessation
among women who smoked at baseline. (Assumptions for
the power calculation were (1) the smallest clinically rele-
vant difference (‘Δ’) is a 5% decrease in smoking com-
pared to baseline, (2) the proportion of women smoking
at baseline is 30% (π0=30%)42 43 (3) a random drop-out
rate of 10%, (4) pairwise analysis of results, (5) a statistical
signiﬁcance level of α<0.025 (one-sided correction for
multiple testing due to primary outcome measures) and
(6) a power (1-β) of 0.80.)
Thus, the cohort study should comprise 839 women to
meet the needs of both primary outcomes.
Organisation and time schedule
Municipalities were encountered for participation from
June 2011 to November 2013. General practices and
midwife practices were encountered for participation
from November 2011 to July 2013. They were prepared
to deliver PCC in the PCC substudy after a one-on-one
training to deliver PCC according to the study protocol.
They received a self-study e-learning course and study
material about PCC in general and about risk factors.
Practices were provided with information leaﬂets, posters
and kits to hand out for the laboratory tests.
Recruitment strategies were rolled out when practices
were ready to receive participants for the study. Data col-
lection is performed in close collaboration with the prac-
tices by means of the Gemstracker system. In order to
promote the readiness of study participants to provide
blood and urine samples and to ensure timely handling
of the samples, all laboratory sampling and processing
are performed at neighbourhood health centres or local
laboratories in the participating municipalities. Finally,
to reduce bias, the non-time critical laboratory tests are
performed at one central laboratory (the trial laboratory
of the Erasmus Medical Center of Rotterdam, the
Netherlands). After each PCC consultation study, partici-
pants receive a preassembled laboratory kit from their
PCC provider. This kit includes 1 mL freezer capsules, a
urine container and an application form to process the
material according to the standard operating procedure
of our study. All local laboratories were accredited by
CCKL (in Dutch: Coördinatie Commissie ter bevorder-
ing van de Kwaliteitsbeheersing op het gebied van
Laboratoriumonderzoek in de Gezondheidszorg or the
organisation that audits laboratories in the healthcare
system in the Netherlands).44 Blood samples are col-
lected in EDTA, SST or sodium ﬂuoride vacutainers (in
size and numbers as routine to the local laboratories).
Local laboratories perform tests which have to be per-
formed within 1 h (eg, glucose) or before refrigeration
(haemoglobin, haematocrit, mean corpuscular volume,
red blood cell count) directly after blood sampling. Two
mL of whole blood is then pipetted and stored and the
remainder is centrifuged (depending on local
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equipment: ±2000 g/10 min). Approximately 2 mL of
plasma and 7 mL of serum is pipetted into 1 mL freezer
capsules. Urine is centrifuged (depending on local
equipment: ±2000 g/10 min) after which 4 mL is stored.
Whole blood is stored at −20°C; plasma/serum fraction
and urine at −70 or 80°C (depending on local equip-
ment). All laboratories closely monitor their storing
protocol and are able to provide a report of the storing
conditions at request. At set times, all samples are distrib-
uted to the central trial laboratory. The ﬁrst municipality
started enrolment in February 2013 and the last munici-
pality started inclusion in February 2014. Enrolment is
ongoing until the time period: April 2014 or until the cal-
culated sample size of included participants has been
reached to meet current research goals. As the sample
size has not been reached as yet, the inclusion period is
currently planned until December 2014.
Ethical considerations
The HP4ALL PCC substudy has been approved by the
Medical Ethical Committee of the Erasmus Medical
Center of Rotterdam (MEC 2012-425). In line with regu-
lations, an independent physician is available for con-
sultation by the (eligible) study population.
DISCUSSION
The Healthy Pregnancy 4 All—PCC substudy aims to
provide evidence for comprehensive and systematic deliv-
ery of PCC to the general public that contemplates preg-
nancy and to identify effective ways to reach women to
promote utilisation of the PCC health services. The study
is rolled out in municipalities with disadvantaged perinatal
health. Outcome measures of the study are the effective-
ness of the employed recruitment strategy and the effect-
iveness of the PCC service in achieving behavioural
change regarding preconception risk behaviours. In doing
so, we acknowledge that merely providing PCC is insufﬁ-
cient and we aim to develop an integrated approach in
which recruitment is combined with delivery of PCC—
ultimately to improve perinatal healthcare by PCC.
Internationally, PCC is implemented in various ways and
within different settings. This study will place PCC in a
cross-domain perspective in the Netherlands for the ﬁrst
time as multidisciplinary collaborations are initiated
among municipalities, public health services and the cura-
tive care setting. Although this can be a strength, it might
also be challenging to motivate different partners with dif-
ferent points of departure in the health system. Prior to
this programme, for instance, the role of public health in
fetal-maternal healthcare was very limited. Furthermore,
PCC has been brought under attention within general
practice and midwifery. However, the experience seems to
be that PCC is, at best, only delivered at a small scale within
these echelons. By implementing PCC in these echelons in
the context of the current study, more can be learnt about
what is necessary to upscale delivery of PCC, if effective.
A limitation in our approach to improve perinatal
health outcome with PCC is that we target the group that
plans pregnancy, as this is a precondition for PCC.
Although the Netherlands has a high planned pregnancy
rate and excellent access to contraceptives,12 43 planned
pregnancy rates and the access to contraceptive care
could be lower within a population with lower socio-
economic status. Initially, we aim to optimise outcomes of
planned pregnancies. If this is effective, it would be the
time to assess where PCC and family planning could be
integrated to increase further effectiveness.
A limitation in the assessment of the effectiveness of
PCC consultations will be that the sampled population
could be prone to a participation bias. First, since the
eligible population will rely on the extent to which the
recruitment strategy is able to recruit a study population
that is representative of the community. Second,
eligible high-risk women might be more difﬁcult to
include in the effectiveness study. However, we believe
that we will have the data to explore the representative-
ness of the included population in relation to the popu-
lation that did not want to participate in the cohort
study and in relation to the targeted population in the
community.
This is one of the ﬁrst cohort studies in the
Netherlands that assesses effectiveness of a PCC
approach in a high-risk area in a general practitioner
and midwifery setting. We have future aspirations to do
further research within the context of this study.
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